“The hugely complex eco-system that is healthcare and Life sciences needs help to operate more efficiently and in particular to align and focus the right expertise and stakeholders on the best opportunities. I believe CASMI can play this critical role”
Mike has been a strategic advisor on healthcare and life sciences for over 20 years.
He has been at the forefront of driving change in the pharmaceutical industry, working at both individual company and industry association level. He has redesigned the pharmaceutical go to market model, transformed support service functions and set up new business ventures. He has supported clients with product development strategies and pricing and market access strategies across a range of therapy areas including oncology, respiratory, cardio-vascular disease, CNS and vaccines. Most recently he has worked on assessing the implications of Value-based pricing in England on product portfolios and individual therapy areas.
In healthcare his work has included the design and launch of key NHS reforms including leading the DH assessment process for the launch of all NHS Trusts and the development of the internal market costing and pricing framework. He has led several major option appraisals and business cases concerned with the redevelopment and reconfiguration of services among London Academic Health Science Centres. In Canada, he was appointed by the provincial government of Ontario to facilitate the merger of a major academic health science centre with a general hospital and community services provider. He also led a rural ‘whole system’ redesign initiative and developed a new business model for the delivery of laboratory services in downtown Toronto.
His leadership positions have included being the Partner responsible for the healthcare consulting practice in KPMG UK and in KPMG Canada, the Partner responsible for the UK life sciences consulting practice at PwC, the Partner responsible for the European healthcare consulting practice of IBM and the CEO of a specialist life sciences research and consulting company.